购物车
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • CDK
    (4)
  • ERK
    (1)
  • P-gp
    (1)
  • Others
    (3)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (1)
  • 6-8周
    (3)
TargetMol | Tags 通过 研究领域 筛选
  • 癌症
    (3)
  • 免疫
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "cdk7/9 in 1"的结果
筛选
搜索结果
TargetMol产品目录中 "

cdk7/9 in 1

"的结果
  • 抑制剂&激动剂
    5
    抑制剂&激动剂
  • 多肽产品
    1
    多肽产品
  • CDK7/9-IN-1
    CDK7/9-IN-1
    T403532747919-19-1
    CDK7/9-IN-1 is a specific inhibitor of cyclin-dependent kinases 7/9 (CDK7/9). It specifically targets CDK7, while also displaying inhibitory activity against CDK9. CDK7/9-IN-1 demonstrates excellent inhibitory potency against CDK7, with IC50 values of 0.0656 μM and 0.00574 μM without pre-incubation and after 3 hours pre-incubation, respectively. Furthermore, CDK7/9-IN-1 inhibits CDK9 with an IC50 of 2.14 μM after 3 hours pre-incubation. Its application in cancer research makes it valuable for such investigations.
    • ¥ 10600
    6-8周
    规格
    数量
  • Olomoucine II
    奥罗莫星 II
    T35696500735-47-7
    Olomoucine II 是一种高效的细胞周期蛋白依赖性激酶抑制剂,对 CDK1、CDK2、CDK4、CDK7 和 CDK9 的 IC50 分别为 7.6、0.1、19.8、0.45 和 0.06 μM。Olomoucine II 对多种其他激酶具有较高选择性,同时对 ERK2 和 ABCB1 保持可检测的活性。Olomoucine II 可在不同 p53 状态的癌细胞系中抑制细胞增殖,并在 ABCB1 表达的 HCT-8 细胞中与 daunorubicin 产生协同作用。此外,Olomoucine II 还能抑制 HSV-1、HSV-2、痘苗病毒、腺病毒 4 型及人巨细胞病毒的复制,是一种重要的抗病毒和抗癌研究工具。
    • ¥ 1080
    现货
    规格
    数量
  • CDK7/9 tide
    T36743
    CDK7/9 tide is peptide substrate for CDK7 or CDK9[1]. [1]. Robert T, et, al. Development of a CDK10/CycM in vitro Kinase Screening Assay and Identification of First Small-Molecule Inhibitors. Front Chem. 2020 Feb 27; 8:147.
    • ¥ 1587
    待询
    规格
    数量
  • CDK7-IN-16
    T627912765676-32-0
    CDK7-IN-16 (compound 9) 是一种 CDK 7 的有效抑制剂 (IC50: 1-10 nM)。CDK7-IN-16 能够用于研究抗癌,特别是转录异常的癌症。
    • ¥ 10600
    6-8周
    规格
    数量
  • Ibulocydine
    T709881314096-68-8
    Ibulocydine is a potent CDK inhibitor. Ibulocydine has high activity against Cdk7/cyclin H/Mat1 and Cdk9/cyclin T. Ibulocydine inhibited the growth of HCC cells more effectively than other Cdk inhibitors, including olomoucine and roscovitine, whereas ibulocydine as well as the other Cdk inhibitors and BMK-Y101 minimally influenced the growth of normal hepatocyte cells. Ibulocydine induced apoptosis in HCC cells, most likely by inhibiting Cdk7 and Cdk9. In vitro treatment of HCC cells with ibulocydine rapidly blocked phosphorylation of the carboxyl-terminal domain (CTD) of the large subunit of RNA polymerase II, a process mediated by Cdk7/9. Anti-apoptotic gene products such as Mcl-1, survivin, and X-linked IAP (XIAP) are crucial for the survival of many cell types, including HCC. Following the inhibition of RNA polymerase II phosphorylation, ibulocydine caused rapid down-regulation of Mcl-1, survivin, and XIAP, thus inducing apoptosis. Furthermore, ibulocydine effectively ind......
    • ¥ 11700
    6-8周
    规格
    数量